Future Market Insights projects the global gastric cancer nutrition market to grow at an 8.8% CAGR from 2026 to 2036, driven by post-gastrectomy nutritional requirements, perioperative immunonutrition, specialized oral supplements, and long-term patient recovery needs.
Market Research Report: Gastric Cancer Nutrition Market
Forecast Period: 2026–2036
Market Size (2026): USD 260.5 million
Projected Market Size (2036): USD 605.4 million
CAGR (2026–2036): 8.8%
Request full Report Pricing and Sample Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-35825
Global Gastric Cancer Nutrition Market Forecast Signals Opportunities for Clinical Nutrition Suppliers
The global gastric cancer nutrition market is expanding as healthcare providers focus on nutritional management before and after stomach cancer surgery. According to Future Market Insights (FMI), the market is estimated at USD 260.5 million in 2026 and is projected to reach USD 605.4 million by 2036, registering a CAGR of 8.8% during the forecast period.
Gastric cancer treatments, particularly partial and total gastrectomy, can significantly reduce patients’ eating capacity and increase the risk of malnutrition. This creates demand for specialized oral nutritional supplements, perioperative immunonutrition, enteral feeding formulas, and targeted micronutrient replacement products.
What Is Driving Growth in the Gastric Cancer Nutrition Market?
Demand is supported by the increasing importance of medical nutrition therapy throughout the gastric cancer treatment journey. Surgical procedures can affect digestion, nutrient absorption, and regular food intake, making specialized nutritional support important during recovery.
Perioperative nutrition is another major growth driver. Clinical recommendations encourage nutritional assessment and appropriate immunonutrition before or around major cancer surgeries to support patient recovery.
Long-term nutritional management also creates opportunities. Patients who undergo stomach removal may require continued dietary monitoring and supplementation to address deficiencies involving vitamin B12, iron, vitamin D, and calcium.
However, gastrointestinal side effects, patient compliance, and cost-conscious prescribing practices can influence supplementation duration and product selection.
Post-Gastrectomy Supplements and Perioperative Care Create Segment Opportunities
FMI identifies Post-Gastrectomy Small-Volume ONS as the leading product type, accounting for 48.6% of market share in 2026, equivalent to approximately USD 126.6 million.
By treatment phase, perioperative nutrition represents the leading segment with a 42.2% share, valued at approximately USD 109.9 million in 2026. This reflects the importance of nutritional intervention around major surgical procedures.
Ready-to-drink (RTD) products account for 42.3% of the product form segment, offering convenient nutritional support without preparation requirements.
These segments highlight opportunities for clinical nutrition manufacturers developing compact, high-calorie supplements and specialized formulations for patients with reduced eating capacity.
Regional Outlook: Japan Leads Gastric Cancer Nutrition Market Growth
FMI’s country-level projections identify Japan as the fastest-growing profiled market, with a projected CAGR of 9.5% from 2026 to 2036.
South Korea follows at 9.2%, supported by established national stomach cancer screening programs. The United States is projected to grow at 8.4%, followed by the United Kingdom at 8.1% and Germany at 7.8%.
Japan’s specialist gastric surgery infrastructure and clinical research into postoperative oral nutritional supplements create opportunities for medical nutrition suppliers. Meanwhile, South Korea’s biennial stomach screening program for adults aged 40 and above supports established diagnostic and treatment pathways.
Competitive Landscape: Top Players in the Gastric Cancer Nutrition Market
Competition includes global clinical nutrition manufacturers and specialized medical nutrition suppliers. FMI identifies the following eight companies in its market analysis:
- Otsuka Pharmaceutical — Clinical and enteral nutrition products.
- Nestlé Health Science — Specialized medical nutrition solutions.
- Danone Nutricia — Oral nutritional supplements and clinical nutrition.
- Abbott — Medical nutrition and specialized nutritional formulations.
- Meiji Holdings — Nutrition and healthcare-related products.
- Ajinomoto — Amino acid-based nutrition and healthcare solutions.
- Fresenius Kabi — Clinical nutrition and enteral feeding products.
- Medtrition — Specialized medical nutrition products.
These companies participate in the broader clinical nutrition landscape, with competitive opportunities shaped by product suitability, institutional purchasing, clinical recommendations, and regional prescribing requirements.
Strategic Priorities for Businesses Entering the Gastric Cancer Nutrition Market
Develop patient-specific formulations: Focus on compact, nutrient-dense supplements suitable for patients experiencing reduced stomach capacity.
Strengthen clinical partnerships: Collaborate with hospitals, cancer centers, dietitians, and healthcare professionals to support product adoption.
Improve product tolerability: Address gastrointestinal side effects and develop formulations that encourage consistent patient compliance.
Expand ready-to-use offerings: Develop convenient RTD products for patients requiring nutritional support during recovery.
Build regional distribution networks: Understand healthcare reimbursement systems, prescribing guidelines, and institutional procurement requirements.
Future Outlook for the Global Gastric Cancer Nutrition Market
The projected expansion of the gastric cancer nutrition market creates opportunities for clinical nutrition manufacturers, healthcare suppliers, and specialized medical food businesses. However, long-term growth will depend on patient tolerability, clinical acceptance, appropriate product selection, and reliable access to nutritional support throughout treatment and recovery.
Access the Full Gastric Cancer Nutrition Market Report
For detailed market forecasts, segmentation, regional analysis, competitive insights, and strategic opportunities, access the full report from Future Market Insights:
https://www.futuremarketinsights.com/reports/gastric-cancer-nutrition-market
Explore More Research Reports by FMI
Pulmonary Rehabilitation Nutrition Market –
https://www.futuremarketinsights.com/reports/pulmonary-rehabilitation-nutrition-market
Diabetic Renal Nutrition Market –
https://www.futuremarketinsights.com/reports/diabetic-renal-nutrition-market
About Future Market Insights (FMI)
Future Market Insights, Inc. (FMI) is an ESOMAR-certified, ISO 9001:2015 market research and consulting organization, trusted by Fortune 500 clients and global enterprises. With operations in the United States, the United Kingdom, India, and Dubai, FMI provides data-backed insights and strategic intelligence across more than 30 industries and 1,200 markets worldwide.
For Press & Corporate Inquiries
Rahul Singh AVP – Marketing and Growth Strategy
Future Market Insights, Inc.
+91 8600020075
For Sales: sales@futuremarketinsights.com
For Media: Rahul.singh@futuremarketinsights.com
